MRP: ₹20360
₹16610
₹ 3750 Off
(Incl. of all taxes)
Qty
Buying in bulk?
In stock Only 5 left
Deliver to
- 7-day returns
- Secure payment
- International shipping
- Carefully packed
Get this at ₹ 15780Extra 5% OffAdd items worth ₹999 to the cart & get extra 5% off
Get this at ₹ 14949Extra 10% OffAdd items worth ₹1499 to the cart & get extra 10% off
Book Summary
This volume includes information on recent advances in five important areas: an
account of inhibitors of the caspase family of proteolytic enzymes that
represent a new class of anti-inflammatory and antiapoptotic agents of potential
value in rheumatoid arthritis; and a survey of semi-synthetic and totally
synthetic antibiotics and anti-HIV agents and their sites of interaction; the
development of inhibitors of the intracellular enzyme acyl-CoA: cholesterol
O-acyltransferase (ACAT) for the treatment of hypercholesterolemia; a
description of recent progress in growth hormone secretagogues, with the focus
on strategies to improve oral bioavailability and duration of action; and
information on inhibition of the proteolytic enzyme, hepatitis C protease
N-3(NS3), (required for vital
- ISBN-13
- 9780444511430
- Language
- English
- Binding
- Hard Bound
- Publisher
- Elsevier Science & Technology
- Publishing Date
- 2004-04-15
- Total Pages
- 410
Progress In Medicinal Chemistry, Vol. 42
by F. D. King (Author),
Elsevier Science & Technology (Publisher)
fictionfantasyyoung adultaward winning
Frequently bought together
Total for 3 items₹16736₹20500You save ₹3764
Product Specifications
Book Summary
This volume includes information on recent advances in five important areas: an
account of inhibitors of the caspase family of proteolytic enzymes that
represent a new class of anti-inflammatory and antiapoptotic agents of potential
value in rheumatoid arthritis; and a survey of semi-synthetic and totally
synthetic antibiotics and anti-HIV agents and their sites of interaction; the
development of inhibitors of the intracellular enzyme acyl-CoA: cholesterol
O-acyltransferase (ACAT) for the treatment of hypercholesterolemia; a
description of recent progress in growth hormone secretagogues, with the focus
on strategies to improve oral bioavailability and duration of action; and
information on inhibition of the proteolytic enzyme, hepatitis C protease
N-3(NS3), (required for vital
Book Specifications
- ISBN-13
- 9780444511430
- Language
- English
- Binding
- Hard Bound
- Publisher
- Elsevier Science & Technology
- Publishing Date
- 2004-04-15
- Total Pages
- 410